Anzeige
Mehr »
Login
Mittwoch, 11.09.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Die Goldaktie, die sogar KI-Giganten in den Schatten stellt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14YWP | ISIN: US86881A1007 | Ticker-Symbol: 1SP
Tradegate
06.09.24
17:41 Uhr
26,600 Euro
-0,800
-2,92 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SURGERY PARTNERS INC Chart 1 Jahr
5-Tage-Chart
SURGERY PARTNERS INC 5-Tage-Chart
RealtimeGeldBriefZeit
26,60027,40010.09.
26,60027,40010.09.
ACCESSWIRE
389 Leser
Artikel bewerten:
(2)

Ascend Plastic Surgery Partners: Hedden & Gunn Plastic Surgery Welcomes New Facial Plastic Surgeon, Dr. Beau Vandiver, Expanding Team Excellence

BIRMINGHAM, AL / ACCESSWIRE / August 7, 2024 / Hedden & Gunn Plastic Surgery, a distinguished member of Ascend Aesthetic Partners, announces the appointment of Dr. Beau Vandiver as its newest facial plastic surgeon, effective July 31, 2024. Dr. Vandiver joins the esteemed practice, bringing a wealth of expertise and a dedication to advancing patient care in the Birmingham, Alabama area.



Dr. Vandiver obtained his Doctor of Medicine degree from the University of Texas Medical Branch, where he graduated summa cum laude. He completed his fellowship training in facial plastic and reconstructive surgery at Rousso Adams Facial Plastic Surgery in Birmingham. Dr. Vandiver has distinguished himself with a commitment to excellence and collaboration, embodying the values upheld by Hedden & Gunn Plastic Surgery and Ascend Aesthetic Partners.

"We are pleased to welcome Dr. Vandiver to our team," said Dr. William Hedden, Chief Surgeon and co-founder of Hedden & Gunn. "His exceptional training and compassion make him a perfect fit for our practice. As part of the Ascend network, we are committed to enhancing our capabilities and providing our patients the highest standard of care."

Dr. Vandiver's arrival expands Hedden & Gunn's capabilities, particularly in facial plastic and reconstructive surgery. He joins Dr. Joshua Halka, a member of Hedden & Gunn's surgical team since 2023, renowned for his expertise in surgical and non-surgical procedures including breast augmentation, breast lift, liposuction, facelift, eyelid surgery, Botox and dermal filler treatments.

A board-eligible plastic surgeon, Dr. Halka completed his medical education in Michigan at Wayne State University School of Medicine in Detroit and his residency program at Oakland University William Beaumont School of Medicine in Royal Oak. His dedication to achieving natural-looking results has earned him recognition throughout the Birmingham community.

"Dr. Vandiver's addition strengthens our commitment to providing Birmingham with the highest standard of facial plastic surgery," said Stephen Gunn, M.D., Chief Surgeon and co-founder of Hedden & Gunn. "We are also proud of Dr. Halka's contributions to our practice and the exceptional team we are building as the leading aesthetics center in the region."

Both Dr. Vandiver and Dr. Halka will collaborate within Hedden & Gunn's state-of-the-art facilities, offering a comprehensive range of cosmetic and reconstructive procedures under the guidance and support of Ascend Aesthetic Partners.

"Expanding our team with skilled surgeons like Dr. Beau Vandiver and Dr. Joshua Halka ensures that we continue to meet the evolving needs of our patients with excellence and compassion," said Dr. Gunn. "Their expertise in facial plastic and reconstructive surgery, coupled with their dedication to our Birmingham community, aligns perfectly with our commitment to advancing aesthetic medicine and delivering outstanding results."

For more information about Hedden & Gunn Plastic Surgery or to schedule a consultation with Dr. Halka or Dr. Vandiver, please contact their Birmingham, Alabama practice at (205) 980-1744.

About Hedden & Gunn Plastic Surgery: Hedden & Gunn Plastic Surgery, a member of the Ascend Aesthetic Partners network, is dedicated to delivering exceptional plastic surgery and aesthetic services. Led by Board-Certified Plastic Surgeons Dr. William Hedden and Dr. Stephen Gunn, the practice is committed to achieving natural-looking results with a focus on patient safety, comfort, and satisfaction.

Ascend Aesthetic Partners unites top plastic surgeons dedicated to advancing aesthetic medicine and empowering patients to become their best selves. Board certified plastic surgeons interested in learning more about the Ascend network can visit ascendaestheticpartners.com.

Contact Information

Lori Moonen
Marketing Agency
lori@creativesparkjax.com
9042287318

Related Images

Hedden & Gunn Plastic Surgery

Hedden & Gunn Plastic Surgery
Logo

SOURCE: Ascend Aesthetic Partners

.

View the original press release on newswire.com.

© 2024 ACCESSWIRE
Besser als NVIDIA! 3 KI- Favoriten mit riesigem Potenzial

Erleben Sie die KI-Revolution und sichern Sie sich gigantische Gewinne!

Nutzen Sie die einmalige Gelegenheit, die Ihnen die Künstliche Intelligenz bietet! Unser exklusiver Aktienreport enthüllt drei unglaublich aussichtsreiche KI-Aktien, die von der bahnbrechenden Entwicklung in diesem Sektor massiv profitieren können.

Warum sollten Sie dabei sein?

Weil eine Investition in KI-Unternehmen nicht nur Stabilität bringt, sondern auch das Potenzial hat, Ihr Depot explosionsartig wachsen zu lassen. Die letzten Jahre haben bewiesen: Wer auf KI setzt, kann außergewöhnliche Gewinne einfahren. Jetzt, nach einer kurzen Konsolidierungsphase, öffnen sich wieder sensationelle Einstiegsmöglichkeiten.

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche KI-Aktien das größte Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen die besten Investments im KI-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.